Compare MOH & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOH | EMN |
|---|---|---|
| Founded | 1980 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.0B |
| IPO Year | 2002 | 1996 |
| Metric | MOH | EMN |
|---|---|---|
| Price | $141.53 | $69.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $170.17 | $78.57 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.92 | 4.10 |
| Revenue | ★ $45,426,000,000.00 | $8,752,000,000.00 |
| Revenue This Year | $3.59 | $1.75 |
| Revenue Next Year | $6.30 | $3.32 |
| P/E Ratio | ★ $15.86 | $16.94 |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $121.06 | $56.11 |
| 52 Week High | $359.97 | $94.11 |
| Indicator | MOH | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 34.07 |
| Support Level | $133.40 | $66.44 |
| Resistance Level | $154.95 | $70.51 |
| Average True Range (ATR) | 7.19 | 2.81 |
| MACD | 0.83 | -1.27 |
| Stochastic Oscillator | 6.09 | 15.42 |
Molina provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in just four states—California, New York, Texas, and Washington—account for over half of its enrollees.
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.